John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Cue Biopharma
CUE
$168M
| $326K | ﹤0.01% |
4,362
-1,530
| -26% | -$179K |
|
|
KNDI
1977
Kandi Technologies Group
KNDI
$65.1M
| $326K | ﹤0.01% |
135,701
+32,536
| +32% | +$84.6K |
|
1978
Bank First Corp
BFC
$1.71B
| $325K | ﹤0.01% |
4,286
-191
| -4% | -$13.8K |
|
|
AHRT
1979
AH Realty Trust
AHRT
$502M
| $324K | ﹤0.01% |
25,225
-83,413
| -77% | -$1.13M |
|
1980
Spero Therapeutics
SPRO
$71M
| $324K | ﹤0.01% |
437,280
+358,372
| +454% | +$1.04M |
|
1981
Neurogene
NGNE
$793M
| $322K | ﹤0.01% |
15,624
+3,425
| +28% | +$83.5K |
|
|
NPTN
1982
DELISTED
NEOPHOTONICS CORP
NPTN
| $322K | ﹤0.01% |
20,498
-73,409
| -78% | -$1.12M |
|
1983
4D Molecular Therapeutics
FDMT
$850M
| $321K | ﹤0.01% |
45,995
+30,295
| +193% | +$295K |
|
1984
Townsquare Media
TSQ
$104M
| $320K | ﹤0.01% |
39,063
+4,273
| +12% | +$44.2K |
|
1985
VanEck Semiconductor ETF
SMH
$64.8B
| $318K | ﹤0.01% |
+3,120
| New | +$362K |
|
1986
ACNB Corp
ACNB
$655M
| $316K | ﹤0.01% |
10,650
-6,026
| -36% | -$201K |
|
1987
Banc of California
BANC
$2.95B
| $316K | ﹤0.01% |
+17,912
| New | +$327K |
|
|
SMED
1988
DELISTED
Sharps Compliance Corp
SMED
| $316K | ﹤0.01% |
108,155
-11,005
| -9% | -$45.9K |
|
1989
Arrow Financial
AROW
$710M
| $314K | ﹤0.01% |
10,474
-6,866
| -40% | -$206K |
|
1990
Lumen
LUMN
$5.85B
| $312K | ﹤0.01% |
+28,622
| New | +$321K |
|
|
KAMN
1991
DELISTED
Kaman Corp
KAMN
| $312K | ﹤0.01% |
+9,974
| New | +$370K |
|
|
CLSD
1992
DELISTED
Clearside Biomedical
CLSD
| $311K | ﹤0.01% |
14,126
-8,174
| -37% | -$198K |
|
1993
WhiteHorse Finance
WHF
$151M
| $311K | ﹤0.01% |
23,652
-93,956
| -80% | -$1.33M |
|
1994
West Bancorporation
WTBA
$485M
| $311K | ﹤0.01% |
12,780
-3,696
| -22% | -$92.1K |
|
1995
Associated Banc-Corp
ASB
$5.84B
| $310K | ﹤0.01% |
+16,970
| New | +$343K |
|
1996
First Community Bankshares
FCBC
$937M
| $310K | ﹤0.01% |
10,554
+1,713
| +19% | +$47.8K |
|
1997
NVE Corp
NVEC
$516M
| $310K | ﹤0.01% |
+6,658
| New | +$323K |
|
1998
Woori Financial
WF
$16.9B
| $310K | ﹤0.01% |
+10,959
| New | +$386K |
|
1999
ProQR Therapeutics
PRQR
$343M
| $306K | ﹤0.01% |
393,248
-351,129
| -47% | -$262K |
|
|
CLDT
2000
Chatham Lodging
CLDT
$642M
| $305K | ﹤0.01% |
29,200
-145,390
| -83% | -$1.83M |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.